Hans-Dieter Volk Profile Page
| Organisation: | Charité |
| Institute: | Institute of Medical Immunology |
| Address: | Charitéplatz 1 10117 Berlin |
| Campus: | Mitte |
| E-Mail: | This e-mail address is being protected from spam bots, you need JavaScript enabled to view it |
| Field: | Medical Immunology |
| Track(s): | Bio;Med |
| CV: | 2006-present Head of the Berlin-Brandenburg Center for Regenerative Therapies 1994-present Head of the Institute of Medical Immunology, Humboldt-University Berlin 1994 Professorship for Immunology at the Humboldt-University, Charité 1989-1990 Hospitation (Sabatical) at the Institute of Immunology, Free University Berlin 1988 Docent for Immunology, Humboldt-University Berlin 1987 Head of the Division of Clinical Immunology at the Institute of Med. Immunology, Humboldt-University Berlin 1987 Fellowship in Hematology/Clinical Immunology,University Innsbruck, Austria 1987 PhD 1986 Medical Specialist in Clinical Immunology 1985-1987 Senior Scientist in Immunology, Humboldt-University Berlin 1984-1985 Fellowship in Immunology University Rostock, FRG 1982-1984 Fellowship in Immunology, Humboldt-University Berlin including 1 year clinical education in dermatology/internal medicine 1980-1982 MD student / residency in Immunology, Humboldt-University Berlin 1974-1980 School of Medicine, Humboldt-University Berlin Study of Human Medicine |
| Research Interests: | The Institute of Medical Immunology want to be a bridge between basic research and clinical research. To realize this concept, both MD´s and PhD´s together with MD and PhD students form the scientific team and the institute offers to Clinical Departments guest working places (8-10). Interdisciplinary groups (Transplant Research Group and Molecular Pathology together with the Depts. of Nephrology and Dermatology, respectively) further improve the interactive work between the institute and clinical groups. In addition, we have closed collaborations with small Biotech enterprises (three of them - Probiogen AG, Jerini AG, GenPat77 AG - were sourced out from the institute - with >100 people) as well as big pharma (joined group with Schering AG). * The scientific topics are transplant immunology * immunology of viral infections (CMV, EBV) * immunology of sepsis * development of standardised immune monitoring * immune dermatology * protein-protein-interactions (independent C3 professorship) * biological clock (junior professorship) |
| Publications: | Hammer MH, Bestrich G, Andree H, Engelmann E, Rosenberger C, Tillmann H, Zwinger S, Babel N, Nickel P, Volk H-D, Reinke P (2006) HLA Type-independent method to monitor polyoma BK virus-specific CD4+ and CD8+ T-cell immunity. Am J Transpl 6: 625 – 631 Hammer M H, Meyer S, Brestrich G, Moosmann A, Kern F, Tesfa L, Babel N, Mittenzweig W, Rooney CM, Hammerschmidt W, Volk H-D, Reinke P (2005) HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy. Eur J Immunol 35: 2250-2258 Zenclussen AC, Gerlof K, Zenclussen ML, Sollwedel A, Bertoja AZ, Ritter T, Kotsch K, Leber J, Volk H-D (2005) Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 166: 811-822 Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G, Proesch S, Reinke P, Volk H-D, Lehmkuhl H, Kern F (2005) Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 201: 1031-1036 Asadullah K, Sterry W, Volk H-D (2003) IL-10 therapy – Review of a new approach. PharmacolRev 55: 241–269 Prass K, Meisel C, Höflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk H-D, Meisel A (2003) Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation . J Exp Med 5: 725-736 Wandinger KP, Lünemann JD, Wengert O, Bellmann-Strobl J, Aktas O, Weber A, Grundström E, Ehrlich S, Wernecke KD, Volk H-D, Zipp F (2003) TNF-related apoptosis inducing ligand (TRAIL) as a po-tential response marker for interferon-beta treatment in multiple sclerosis. Lancet 361: 2036 Niebauer J, Volk H-D, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-WilsonPA, Coats AJS, Anker SD (1999) Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353: 1838-1840 Kern F, Surel IP, Freistedt B, Scheffold A, Blasczyk R, Reinke P, Schneider-Mergener J,Radbruch A, Walden P, Volk H-D (1998) T-cell epitope mapping by flow cytometry. Nat Med 8: 975-978 Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schoning B, Glockner F,Lanksch WR, Volk H-D, Docke WD (1998) Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 4: 808-813 |
